Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited)

v3.24.1.1.u2
Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - GBP (£)
Common Stock [Member]
Deferred Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2022 £ 95 £ 397,398 £ 33,308,568 £ (33,374,796) £ 331,265
Balance, shares at Dec. 31, 2022 949,958 794,955      
Share-based compensation expense 139,815   139,815
Share-based compensation expense, shares        
Issuance of ordinary shares £ 153 1,280,296 1,280,449
Issuance of ordinary shares, shares 1,530,000      
Net loss (634,911) (634,911)
Balance at Mar. 31, 2023 £ 248 £ 397,398 34,728,679 (34,009,707) 1,116,618
Balance, shares at Mar. 31, 2023 2,479,958 794,955      
Balance at Dec. 31, 2023 £ 2,057 £ 397,398 41,123,065 (38,837,290) 2,685,230
Balance, shares at Dec. 31, 2023 20,570,088 794,955      
Share-based compensation expense £ 242 784,555   784,797
Share-based compensation expense, shares 2,421,400        
Issuance of ordinary shares £ 2,844 16,679 19,523
Issuance of ordinary shares, shares 28,436,153      
Net loss (3,321,854) (3,321,854)
Shares issued in connection with Series D warrant exercise, net of issuance costs £ 1,248 911,544 912,792
Shares issued in connection with Series D warrant exercise, net of issuance costs, shares 12,475,000        
Balance at Mar. 31, 2024 £ 6,391 £ 397,398 £ 42,835,843 £ (42,159,144) £ 1,080,488
Balance, shares at Mar. 31, 2024 63,902,641 794,955